Bioxytran (BIXT) EBITDA Margin (2010 - 2018)
Bioxytran's EBITDA Margin was 20.13% in Q2 2018, up 663.71 percentage points from -643.58% a year earlier but down 7.61 percentage points from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) EBITDA Margin (2010 - 2018) Analysis & Trends
On a trailing twelve-month basis, Bioxytran's EBITDA Margin was -10.72% through Jun 30, 2018, up 172.54 percentage points year-over-year; for FY2017, it was -153.37%, up 107.75 percentage points from FY2016.
- EBITDA Margin shows a five-year change of +565.41 percentage points (FY2012 to FY2017).
- In earlier years, EBITDA Margin was -261.12% in FY2016 (+535.35 pp), -796.47% in FY2015 (-352.92 pp), -443.56% in FY2014 (+16.85 pp) and -460.40% in FY2013 (+258.37 pp).
- Quarterly EBITDA Margin has moved between -3197.83% (Q2 2015) and 243.46% (Q4 2016) over five years.
- Compared with a year earlier, EBITDA Margin was higher in four of the last seven quarters, with an average year-over-year change of +179.56 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q3 2013 (a gain of 4463.87 percentage points); the worst was Q2 2015 (a drop of 3087.88 percentage points).
- Per Business Quant data, BIXT's EBITDA Margin in the three quarters before Q2 2018 was 27.73% (Q1 2018), -254.89% (Q4 2017) and 49.30% (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 20.13% |
| Mar 31, 2018 | 27.73% |
| Dec 31, 2017 | -254.89% |
| Sep 30, 2017 | 49.30% |
| Jun 30, 2017 | -643.58% |
| Mar 31, 2017 | -783.66% |
| Dec 31, 2016 | 243.46% |
| Sep 30, 2016 | -205.02% |
| Jun 30, 2016 | -245.36% |
| Mar 31, 2016 | -1,400.47% |
| Sep 30, 2015 | -12.28% |
| Jun 30, 2015 | -3,197.83% |
| Mar 31, 2015 | -36.27% |
| Sep 30, 2014 | -2,650.17% |
| Jun 30, 2014 | -109.95% |
| Mar 31, 2014 | 38.54% |
| Dec 31, 2013 | -52.23% |
| Sep 30, 2013 | -452.64% |
| Jun 30, 2013 | -636.04% |
| Mar 31, 2013 | -842.34% |
API Access
Bioxytran EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();